Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 6 days ago

BeOne Medicines Ltd.: OYLER JOHN amends Schedule 13G stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 13 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Oyler John amended a Schedule 13G filing on BeOne Medicines Ltd., updating the SEC with accession number 0001104659-26-127046. The filing is a passive-stake disclosure, though the amendment did not specify a change in share count or percentage. Schedule 13G amendments are typically filed when a holder's position moves past certain thresholds or when previously reported information becomes inaccurate. Investors should watch for the next 13G or 13D filing to see whether Oyler's stake in the biopharmaceutical company has materially increased or decreased.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

BeOne Medicines Ltd., OYLER JOHN